Records containing: Macular Degeneration
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2008-03-04Dose Ranging Study of Lutein Supplementation in Persons Over Age 60
-
CLINICAL_TRIALS study record update · 2008-03-04Multi-Center Randomized Phase I/II Trial to Study the Effects of Cyclooxygenase-2 Inhibition on the Response to Photodynamic Therapy in Patients With Age-Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2008-03-04Diabetic Retinopathy and Visual Function Study
-
CLINICAL_TRIALS study record update · 2008-03-04Long Term Follow-Up of Diabetic Retinopathy
-
CLINICAL_TRIALS study record update · 2008-03-04A Randomized, Prospective Study of Sustained-Release Fluocinolone Acetonide Implant for Choroidal Neovascularization Associated With Age-Related Macular Degeneration
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-03-04Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2008-01-09Safety and Efficacy of MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)
-
CLINICAL_TRIALS study record update · 2007-11-28A Phase 2, Randomized, Open Label, Safety, and Pharmacodynamic Study of Squalamine Lactate for Injection for the Treatment of Minimally Classic or Active Occult Choroidal Neovascularization Associated With Age-Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2007-11-28ClinicalTrials.gov study NCT00089830
-
CLINICAL_TRIALS study record update · 2007-07-30A Phase 1, Double-Masked, Placebo-Controlled, Dose-Escalation Study (in Two Parts) of TG100801 and a Colored Vehicle in Adult Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2007-05-07Clinical Study Of EYE001 In Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2007-04-27Subcutaneous Copaxone as Treatment for Dry Age Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2007-01-26A 24 Month Randomized, Double-Masked, Single Center, Phase II Study Comparing Photodynamic Therapy With Verteporfin (Visudyne)Plus Two Different Timing Regimens of Intravitreal Bevacizumab (Avastin) Given 1 Week Prior to or 1 Week Following Photodynamic Therapy in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.
-
CLINICAL_TRIALS study record update · 2007-01-15An Exploratory Randomized, Double-Masked, Multi-Center Comparative Trial, in Parallel Groups, to Explore the Safety and Efficacy of Three Different Doses of Intravitreous Injections of Pegaptanib Sodium (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks for 102 Weeks, in Patients With Subfoveal Neovascular Age-Related Macular Degeneration (AMD)
-
CLINICAL_TRIALS study record update · 2006-09-25A Multicenter, Open Label, Prospective Study to Determine Safety and Efficacy Over an Additional 12-Month Period With Non-Exudative Age-Related Macular Degeneration (With Follow-on to 12-Months)
-
CLINICAL_TRIALS study record update · 2006-07-19Preliminary Multi-Center Assessment of Laser and Medical Treatment of Diabetic Macular Edema
-
CLINICAL_TRIALS study record update · 2006-05-29ClinicalTrials.gov study NCT00032396
-
CLINICAL_TRIALS study record update · 2006-05-03A Phase II Prospective, Randomized, Double-Masked, Sham-Controlled, Dose-Ranging, Multi-Center Trial to Assess the Effect of Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)